| UniProt ID | SEC13_HUMAN | |
|---|---|---|
| UniProt AC | P55735 | |
| Protein Name | Protein SEC13 homolog {ECO:0000305} | |
| Gene Name | SEC13 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 322 | |
| Subcellular Localization |
Cytoplasmic vesicle, COPII-coated vesicle membrane Peripheral membrane protein Cytoplasmic side . Endoplasmic reticulum membrane Peripheral membrane protein Cytoplasmic side . Nucleus, nuclear pore complex . Lysosome membrane . In interphase, |
|
| Protein Description | Functions as a component of the nuclear pore complex (NPC) and the COPII coat. At the endoplasmic reticulum, SEC13 is involved in the biogenesis of COPII-coated vesicles.; As a component of the GATOR subcomplex GATOR2, functions within the amino acid-sensing branch of the TORC1 signaling pathway. Indirectly activates mTORC1 and the TORC1 signaling pathway through the inhibition of the GATOR1 subcomplex. [PubMed: 23723238 It is negatively regulated by the upstream amino acid sensors SESN2 and CASTOR1] | |
| Protein Sequence | MVSVINTVDTSHEDMIHDAQMDYYGTRLATCSSDRSVKIFDVRNGGQILIADLRGHEGPVWQVAWAHPMYGNILASCSYDRKVIIWREENGTWEKSHEHAGHDSSVNSVCWAPHDYGLILACGSSDGAISLLTYTGEGQWEVKKINNAHTIGCNAVSWAPAVVPGSLIDHPSGQKPNYIKRFASGGCDNLIKLWKEEEDGQWKEEQKLEAHSDWVRDVAWAPSIGLPTSTIASCSQDGRVFIWTCDDASSNTWSPKLLHKFNDVVWHVSWSITANILAVSGGDNKVTLWKESVDGQWVCISDVNKGQGSVSASVTEGQQNEQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MVSVINTVD ------CCEEEECCC | 6.69 | 22223895 | |
| 3 | Phosphorylation | -----MVSVINTVDT -----CCEEEECCCC | 18.91 | 24043423 | |
| 7 | Phosphorylation | -MVSVINTVDTSHED -CCEEEECCCCCHHH | 14.50 | 24043423 | |
| 10 | Phosphorylation | SVINTVDTSHEDMIH EEEECCCCCHHHHHC | 27.87 | 24043423 | |
| 11 | Phosphorylation | VINTVDTSHEDMIHD EEECCCCCHHHHHCH | 22.03 | 20071362 | |
| 23 | Phosphorylation | IHDAQMDYYGTRLAT HCHHHHCCCCCEEEE | 9.84 | 20071362 | |
| 24 | Ubiquitination | HDAQMDYYGTRLATC CHHHHCCCCCEEEEC | 14.04 | 21890473 | |
| 24 | Phosphorylation | HDAQMDYYGTRLATC CHHHHCCCCCEEEEC | 14.04 | 20071362 | |
| 26 | Phosphorylation | AQMDYYGTRLATCSS HHHCCCCCEEEECCC | 13.34 | 20071362 | |
| 33 | Phosphorylation | TRLATCSSDRSVKIF CEEEECCCCCCEEEE | 38.91 | - | |
| 35 | Methylation | LATCSSDRSVKIFDV EEECCCCCCEEEEEE | 45.34 | 115493505 | |
| 38 | Ubiquitination | CSSDRSVKIFDVRNG CCCCCCEEEEEECCC | 38.61 | 2189047 | |
| 38 | Acetylation | CSSDRSVKIFDVRNG CCCCCCEEEEEECCC | 38.61 | 26051181 | |
| 38 | 2-Hydroxyisobutyrylation | CSSDRSVKIFDVRNG CCCCCCEEEEEECCC | 38.61 | - | |
| 92 | Phosphorylation | IWREENGTWEKSHEH EEEECCCCEEECHHC | 41.87 | - | |
| 161 | Ubiquitination | NAVSWAPAVVPGSLI CEEEECCCCCCCHHC | 13.75 | 21890473 | |
| 175 | Ubiquitination | IDHPSGQKPNYIKRF CCCCCCCCCCHHHHH | 38.46 | 21890473 | |
| 180 | Ubiquitination | GQKPNYIKRFASGGC CCCCCHHHHHHCCCC | 30.97 | - | |
| 184 | Phosphorylation | NYIKRFASGGCDNLI CHHHHHHCCCCHHHH | 32.76 | 20873877 | |
| 187 | Glutathionylation | KRFASGGCDNLIKLW HHHHCCCCHHHHHHH | 3.41 | 22555962 | |
| 192 | Ubiquitination | GGCDNLIKLWKEEED CCCHHHHHHHHHHCC | 52.00 | - | |
| 195 | Ubiquitination | DNLIKLWKEEEDGQW HHHHHHHHHHCCCCC | 66.73 | - | |
| 207 | Ubiquitination | GQWKEEQKLEAHSDW CCCCHHHHHHHCCHH | 52.12 | - | |
| 212 | Phosphorylation | EQKLEAHSDWVRDVA HHHHHHCCHHHHHHH | 39.97 | - | |
| 223 | Phosphorylation | RDVAWAPSIGLPTST HHHHCCCCCCCCCHH | 22.88 | 21712546 | |
| 233 | Phosphorylation | LPTSTIASCSQDGRV CCCHHEEEECCCCCE | 15.51 | 21712546 | |
| 234 | Glutathionylation | PTSTIASCSQDGRVF CCHHEEEECCCCCEE | 2.90 | 22555962 | |
| 242 | Ubiquitination | SQDGRVFIWTCDDAS CCCCCEEEEECCCCC | 2.45 | 21890473 | |
| 249 | Phosphorylation | IWTCDDASSNTWSPK EEECCCCCCCCCCHH | 30.99 | 28348404 | |
| 250 | Phosphorylation | WTCDDASSNTWSPKL EECCCCCCCCCCHHH | 39.74 | 28348404 | |
| 252 | Phosphorylation | CDDASSNTWSPKLLH CCCCCCCCCCHHHHH | 29.30 | 27251275 | |
| 254 | Phosphorylation | DASSNTWSPKLLHKF CCCCCCCCHHHHHHC | 15.32 | 29507054 | |
| 256 | Ubiquitination | SSNTWSPKLLHKFND CCCCCCHHHHHHCCC | 59.16 | 21890473 | |
| 260 | Ubiquitination | WSPKLLHKFNDVVWH CCHHHHHHCCCEEEE | 45.92 | - | |
| 301 | Phosphorylation | DGQWVCISDVNKGQG CCEEEEEEEECCCCC | 30.31 | 21712546 | |
| 309 | Phosphorylation | DVNKGQGSVSASVTE EECCCCCEEEEEECC | 12.66 | 25159151 | |
| 311 | Phosphorylation | NKGQGSVSASVTEGQ CCCCCEEEEEECCCC | 19.27 | 25159151 | |
| 313 | Phosphorylation | GQGSVSASVTEGQQN CCCEEEEEECCCCCC | 23.28 | 25159151 | |
| 315 | Phosphorylation | GSVSASVTEGQQNEQ CEEEEEECCCCCCCC | 31.72 | 30108239 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SEC13_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SEC13_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SEC13_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309 AND SER-313, ANDMASS SPECTROMETRY. | |